Repository logo
 
Publication

The Clinical Role of LASER for Vulvar and Vaginal Treatments in Gynecology and Female Urology: An ICS/ISSVD Best Practice Consensus Document

dc.contributor.authorPreti, M
dc.contributor.authorVieira-Baptista, P
dc.contributor.authorDigesu, GA
dc.contributor.authorBretschneider, CE
dc.contributor.authorDamaser, M
dc.contributor.authorDemirkesen, O
dc.contributor.authorHeller, DS
dc.contributor.authorMangir, N
dc.contributor.authorMarchitelli, C
dc.contributor.authorMourad, S
dc.contributor.authorMoyal-Barracco, M
dc.contributor.authorPeremateu, S
dc.contributor.authorTailor, V
dc.contributor.authorTarcan, T
dc.contributor.authorDe, EJ
dc.contributor.authorStockdale, CK
dc.date.accessioned2021-04-03T22:37:00Z
dc.date.available2021-04-03T22:37:00Z
dc.date.issued2019-04
dc.description.abstractIn this best practice document, we propose recommendations for the use of LASER for gynecologic and urologic conditions such as vulvovaginal atrophy, urinary incontinence, vulvodynia, and lichen sclerosus based on a thorough literature review. Most of the available studies are limited by their design; for example, they lack a control group, patients are not randomized, follow-up is short term, series are small, LASER is not compared with standard treatments, and most studies are industry sponsored. Because of these limitations, the level of evidence for the use of LASER in the treatment of these conditions remains low and does not allow for definitive recommendations for its use in routine clinical practice. Histological evidence is commonly reported as proof of tissue regeneration after LASER treatment. However, the histological changes noted can also be consistent with reparative changes after a thermal injury rather than necessarily representing regeneration or restoration of function. The use of LASER in women with vulvodynia or lichen sclerosus should not be recommended in routine clinical practice. There is no biological plausibility or safety data on its use on this population of women. The available clinical studies do not present convincing data regarding the efficacy of LASER for the treatment of vaginal atrophy or urinary incontinence. Also, although short-term complications seem to be uncommon, data concerning long-term outcomes are lacking. Therefore, at this point, LASER is not recommended for routine treatment of the aforementioned conditions unless part of well-designed clinical trials or with special arrangements for clinical governance, consent, and audit.pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.citationJ Low Genit Tract Dis . 2019 Apr;23(2):151-160.pt_PT
dc.identifier.doi10.1097/LGT.0000000000000462pt_PT
dc.identifier.urihttp://hdl.handle.net/10400.26/36104
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.subjectTerapia Laserpt_PT
dc.subjectDoenças da Vulvapt_PT
dc.subjectDoenças Vaginaispt_PT
dc.subjectVaginal Diseasespt_PT
dc.subjectVulvar Diseasespt_PT
dc.subjectLaser Therapypt_PT
dc.subjectVupt_PT
dc.titleThe Clinical Role of LASER for Vulvar and Vaginal Treatments in Gynecology and Female Urology: An ICS/ISSVD Best Practice Consensus Documentpt_PT
dc.typejournal article
dspace.entity.typePublication
oaire.citation.endPage160pt_PT
oaire.citation.issue2pt_PT
oaire.citation.startPage151-160pt_PT
oaire.citation.titleJournal of lower genital tract diseasept_PT
oaire.citation.volume23pt_PT
rcaap.rightsopenAccesspt_PT
rcaap.typearticlept_PT

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
J Low Genit Tract Dis.pdf
Size:
398.42 KB
Format:
Adobe Portable Document Format